- Home
- VAL vs VKTX Comparison
VAL vs VKTX Comparison
Compare VAL & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VAL | VKTX |
|---|---|---|
| Founded | 1975 | 2012 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 3.8B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | VAL | VKTX |
|---|---|---|
| Price | $49.79 | $34.33 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 14 |
| Target Price | $55.60 | ★ $87.07 |
| AVG Volume (30 Days) | 971.3K | ★ 2.8M |
| Earning Date | 10-29-2025 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.61 | N/A |
| Revenue | ★ $2,416,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $8.92 | ★ N/A |
| Revenue Growth | ★ 6.81 | N/A |
| 52 Week Low | $27.15 | $18.92 |
| 52 Week High | $61.70 | $48.55 |
Technical Indicators
Market Signals| Indicator | VAL | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 32.22 | 41.55 |
| Support Level | $56.40 | $36.49 |
| Resistance Level | $61.70 | $38.50 |
| Average True Range (ATR) | 2.45 | 1.87 |
| MACD | -1.10 | -0.30 |
| Stochastic Oscillator | 10.98 | 7.69 |
Price Performance
Historical ComparisonAbout VAL Valaris Limited
Valaris Ltd is an offshore contract drilling company. The company provides offshore contract drilling services to the international oil and gas industry with operations in almost every offshore market across six continents. Its business consists of four operating segments: Floaters, which includes drillships and semisubmersible rigs; Jackups; ARO; and Other, which consists of management services on rigs owned by third parties. It generates the majority of its revenue from the Floaters segment.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.